IMMUNOINTERVENTION WITH CYCLOSPORINE-A IN AUTOIMMUNE NEUROLOGICAL DISORDERS

被引:12
作者
TINDALL, RSA
机构
[1] Department of Neurology, Southwestern Medical School, University of Texas, Dallas, TX
关键词
D O I
10.1016/0896-8411(92)90048-U
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cyclosporin A has proven a remarkably effective compound in suppressing disease activity in a number of animal models of autoimmune neurological disorders. During the last decade a number of controlled clinical trials have been carried out in human neurological disorders which are considered to be immune-mediated. The results of those trials are reviewed. © 1992.
引用
收藏
页码:301 / 313
页数:13
相关论文
共 39 条
[1]   A DOUBLE-BLIND-STUDY OF THE EFFECTIVENESS OF CYCLOSPORINE IN AMYOTROPHIC LATERAL SCLEROSIS [J].
APPEL, SH ;
STEWART, SS ;
APPEL, V ;
HARATI, Y ;
MIETLOWSKI, W ;
WEISS, W ;
BELENDIUK, GW .
ARCHIVES OF NEUROLOGY, 1988, 45 (04) :381-386
[2]   MYASTHENIA-GRAVIS - LONG-TERM CORRELATION OF BINDING AND BUNGAROTOXIN BLOCKING ANTIBODIES AGAINST ACETYLCHOLINE-RECEPTORS WITH CHANGES IN DISEASE SEVERITY [J].
BESINGER, UA ;
TOYKA, KV ;
HOMBERG, M ;
HEININGER, K ;
HOHLFELD, R ;
FATEHMOGHADAM, A .
NEUROLOGY, 1983, 33 (10) :1316-1321
[3]   IMMUNOSUPPRESSION BY CYCLOSPORIN A OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J].
BOLTON, C ;
BOREL, JF ;
CUZNER, ML ;
DAVISON, AN ;
TURNER, AM .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1982, 56 (2-3) :147-153
[4]  
Dau P C, 1982, Prog Clin Biol Res, V106, P223
[5]  
DAWIDSON I, 1989, TRANSPLANTATION, V48, P575
[6]   TREATMENT OF EXPERIMENTAL MYASTHENIA-GRAVIS WITH CYCLOSPORIN-A [J].
DRACHMAN, DB ;
ADAMS, RN ;
MCINTOSH, K ;
PESTRONK, A .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1985, 34 (02) :174-188
[7]  
DYCK PJ, 1975, MAYO CLIN PROC, V50, P621
[8]   PLASMA-EXCHANGE IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY [J].
DYCK, PJ ;
DAUBE, J ;
OBRIEN, P ;
PINEDA, A ;
LOW, PA ;
WINDEBANK, AJ ;
SWANSON, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (08) :461-465
[9]   MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I ANTIGEN EXPRESSION, IMMUNOLOCALIZATION OF INTERFERON SUBTYPES, AND T-CELL-MEDIATED CYTO-TOXICITY IN MYOPATHIES [J].
EMSLIESMITH, AM ;
ARAHATA, K ;
ENGEL, AG .
HUMAN PATHOLOGY, 1989, 20 (03) :224-231
[10]   MYASTHENIA-GRAVIS AND MYASTHENIC SYNDROMES [J].
ENGEL, AG .
ANNALS OF NEUROLOGY, 1984, 16 (05) :519-534